Pliant Therapeutics' Series B Round

Pliant Therapeutics raised a round of funding on July 16, 2018.

Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. B…

Articles about Pliant Therapeutics' Series B Round: